Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma: A Prospective Feasibility Study

NCT07845617 is registered in ClinicalTrials.gov with AdventHealth as lead sponsor.

NCT NCT07845617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07845617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma: A Prospective Feasibility Study
Lead sponsor
AdventHealth
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2026
Completion date
May 2, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ampullary adenocarcinoma, duodenal adenocarcinoma, duodenal cancer, pancreas adenocarcinoma, pancreas cancer with hepatic metastase